About NextDocs
NextDocs is a company based in Austin (United States) founded in 2006 was acquired by Aurea in June 2015. NextDocs has raised $28.8 million across 3 funding rounds from investors including Aurea, OpenView and Eastward Capital Partners. The company has 48 employees as of December 31, 2022. NextDocs operates in a competitive market with competitors including Envision Pharma Group, MetricStream, Octagon Research, Qualio and MasterControl, among others.
- Headquarter Austin, United States
- Employees 48 as on 31 Dec, 2022
-
Sectors
TechnologyHealthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Nextdocs Corporation
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of NextDocs
NextDocs has successfully raised a total of $28.8M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $13.5 million completed in September 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in NextDocs
NextDocs has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Aurea, OpenView and Eastward Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
US expansion-stage companies are invested in by OpenView.
|
Locked | Locked | Locked | |
|
Venture debt firm that does debt investment in the US
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for NextDocs
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by NextDocs
Investment portfolio details for NextDocs
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - NextDocs
Detailed financials for NextDocs
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nextdocs Comparisons
Peer comparison for NextDocs
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of NextDocs
NextDocs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Envision Pharma Group, MetricStream, Octagon Research, Qualio and MasterControl, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Compliant global publication planning is offered for life sciences.
|
|
| Locked | Locked | Locked |
Cloud-based regulatory solutions are provided for financial institutions.
|
|
| Locked | Locked | Locked |
Clinical and regulatory information management software is provided for pharmaceuticals.
|
|
| Locked | Locked | Locked |
Web-based quality management software is delivered for life sciences firms.
|
|
| Locked | Locked | Locked |
Provider of governance, risk and compliance solutions for life sciences industries
|
|
| Locked | Locked | Locked |
Legit is recognized as a pioneer in privacy and data protection, offering innovative RegTech solutions.
|
Detailed competitors of NextDocs
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nextdocs
Complete news archive for NextDocs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NextDocs
NextDocs was founded in 2006 and raised its 1st funding round 5 years after it was founded.
NextDocs is headquartered in Austin, United States. It is registered at Austin, Texas, United States.
NextDocs is a funded company, having raised a total of $28.8M across 3 funding rounds to date.
As of Dec 31, 2022, the latest employee count at NextDocs is 48.
NextDocs was founded in 2006 and is headquartered in Austin, United States. Software solutions based on Microsoft Office SharePoint Server are provided for document, quality, and compliance management in the life sciences sector. These tools support regulated industries in meeting FDA and EMA requirements through web-based systems available as SaaS or on-premises deployments. Regulatory documents, SOPs, clinical records, and quality processes including CAPA and complaints are managed.
NextDocs's top competitors include Envision Pharma Group, Qualio and MasterControl.
NextDocs has 4 investors. Key investors include Aurea, OpenView, Eastward Capital Partners, and Bridgebank Capital.